Genomic Markers Associated with Cytomegalovirus DNAemia in Kidney Transplant Recipients
Human cytomegalovirus (CMV) is a major pathogen after solid organ transplantation, leading to high morbidity and mortality. Transplantation from a CMV-seropositive donor to a CMV-seronegative recipient (D+/R−) is associated with high risk of CMV disease. However, that risk is not uniform, suggesting...
Main Authors: | Guy Shapira, Hadas Volkov, Itai Fabian, David W. Mohr, Maria Bettinotti, Noam Shomron, Robin K. Avery, Ravit Arav-Boger |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/15/11/2227 |
Similar Items
-
Evaluating longitudinal cytomegalovirus-specific humoral immune responses and association with DNAemia risk in seropositive lung transplant recipients
by: Melissa J. Harnois, et al.
Published: (2024-08-01) -
Molecular Epidemiology of Cytomegalovirus UL97 and UL54 variants in Taiwan
by: Shu-Li Yang, et al.
Published: (2021-10-01) -
Whole Blood versus Plasma Samples—How Does the Type of Specimen Collected for Testing Affect the Monitoring of Cytomegalovirus Viremia?
by: Mateusz Rzepka, et al.
Published: (2022-11-01) -
Acute and Chronic Changes in Gene Expression After CMV DNAemia in Kidney Transplant Recipients
by: Richard Ahn, et al.
Published: (2021-11-01) -
Epstein–Barr Virus DNAemia and co-occurrence with cytomegalovirus DNAemia in postrenal transplant recipients from a tertiary care center
by: Ramya Barani, et al.
Published: (2018-01-01)